ACTIVITY IN THE THIRD QUARTER OF 2014
(Unaudited data)
Development of business in the third quarter (variation at current rate)
| thousands of euros |
1st Quarter | 2nd Quarter | 3rd Quarter | ||||||
| 2013 | 2014 | Var. 14/13 |
2013 | 2014 | Var. 14/13 |
2013 | 2014 | Var. 14/13 |
|
| France | 84,270 | 82,749 | -1.8% | 75,327 | 74,269 | -1.4% | 92,596 | 92,466 | -0.1% |
| International : | 73,751 | 57,460 | -22.1% | 42,436 | 47,138 | +11.1% | 76,890 | 79,646 | +3.6% |
| Incl. Europe excluding France | 54,334 | 39,967 | -26.4% | 29,047 | 33,570 | +15.6% | 61,256 | 62,758 | +2.5% |
| Incl. North America | 15,562 | 12,662 | -18.6% | 10,017 | 10,625 | +6.1% | 12,153 | 13,109 | +7.9% |
| Incl. Other countries | 3,855 | 4,831 | +25.3% | 3,372 | 2,943 | -12.7% | 3,481 | 3,779 | +8.6% |
| Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | +3.1% | 169,486 | 172,112 | +1.5% |
| thousands of euros |
1st Quarter | 2nd Quarter | 3rd Quarter | ||||||
| 2013 | 2014 | Var. 14/13 |
2013 | 2014 | Var. 14/13 |
2013 | 2014 | Var. 14/13 |
|
| Non-proprietary Homeopathic Medicines | 79,062 | 77,919 | -1.4% | 73,035 | 73,072 | +0.1% | 73,597 | 72,957 | -0.9% |
| OTC Specialties | 78,866 | 62,196 | -21.1% | 44,600 | 48,058 | +7.8% | 95,813 | 99,025 | + 3.4% |
| Other | 93 | 94 | +1.1% | 128 | 277 | +116.4% | 76 | 130 | +71.1% |
| Group Total | 158,021 | 140,209 | -11.3% | 117,763 | 121,407 | +3.1% | 169,486 | 172,112 | +1.5% |
Cumulative activity as of the end of september 2014
| thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| France | 252,193 | 249,484 | - 1.1% | - 1.1% |
| International : | 193,077 | 184,244 | - 4.6% | - 1.2% |
| Incl. Europe excluding France | 144,637 | 136,295 | - 5.8% | - 2.4% |
| Incl. North America | 37,732 | 36,396 | - 3.5% | + 0.4% |
| Incl. Other countries | 10,708 | 11,553 | + 7.9% | + 10.2% |
| Group Total | 445,270 | 433,728 | - 2.6% | - 1.1% |
| thousands of euros | 2013 | 2014 | Variation at current exchange rates | Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 225,694 | 223,948 | - 0.8% | - 0.5% |
| OTC Specialties | 219,279 | 209,279 | - 4.6% | - 1.8% |
| Other | 297 | 501 | + 68.7% | + 63.6% |
| Group Total | 445,270 | 433,728 | - 2.6% | - 1.1% |
Highlights of the third quarter
-
Sales revenue in the third quarter 2014 grew by 1.5% compared to 2013 (3.3% at constant rates).
-
On September 30, 2014, the group cash balance amounted €134.7 million.
Outlook
Considering the uncertainty of seasonal illnesses in the last quarter, the group is still cautious regarding its 2014 outlook.
Our next update: January 22, 2015 at market close, publication of the sales revenue for the year 2014.
Financial information manager: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: [email protected]
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-37682-BOI-231014-CA-T3-14-GB.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews
